PLASMODIUM VIVAX MALARIA
Clinical trials for PLASMODIUM VIVAX MALARIA explained in plain language.
Never miss a new study
Get alerted when new PLASMODIUM VIVAX MALARIA trials appear
Sign up with your email to follow new studies for PLASMODIUM VIVAX MALARIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Malaria-Fighting drug given to entire villages shows promise
Disease control CompletedThis study tested giving a single dose of the drug tafenoquine to everyone in three villages in Myanmar to see if it could safely stop the spread of P. vivax malaria. Over 1,200 people took part, and researchers tracked side effects and malaria cases for six months. The goal was …
Matched conditions: PLASMODIUM VIVAX MALARIA
Phase: PHASE4 • Sponsor: Shoklo Malaria Research Unit • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Could targeted drug dosing stamp out malaria in thai hotspots?
Prevention CompletedThis study tested whether giving antimalarial drugs to everyone in high-risk villages and forest workers could lower malaria cases in Thailand. Over 14,000 people took part. The goal was to see if this approach reduces infections from both Plasmodium falciparum and Plasmodium viv…
Matched conditions: PLASMODIUM VIVAX MALARIA
Phase: NA • Sponsor: University of California, San Francisco • Aim: Prevention
Last updated Jun 27, 2026 12:25 UTC